Kanis J.A., Urwin G.H., Gray R.E.S., Beneton M.N.C., McCloskey E.V., Hamdy
N.A.T., Murray S.A.
Effects of intravenous etidronate on skeletal and calcium metabolism
// Am. J. Med. — 1987. — V. 82. — P. 55 70.
Kanis J.A., O`Rourke N., Mc Closley E.V.
Consequences of neoplasia induced bone
resorption and the use of closronate // Int. J. of Oncology. — 1994. — V. 5. — P. 713 731.
Kanis J.A.
Bone and cancer: pathophysiology and treatment of metastases // Bone. —
1995. — V. 17(Suppl. 2). — P. 101 105.
Kanis J.A., Powles T., Paterson A.H., McCloskey E.V., Ashley S.
Clodronate decreas
es the frequency of skeletal metastases in women with breast cancer // Bone. — 1996. —
V. 19(6). — P. 663 667.
Kanis J.A.
Rationale for the use of bisphosphonates in breast cancer // Acta Oncol. —
1996. — V. 35 (Suppl. 5). — P. 61 67.
Kanis J.A., McCloskey E.V.
Clodronate // Cancer. — 1997. — V. 80(Suppl. 8). —
P. 1691 1695.
Kanis J.A., McCloskey E.V.
Bone turnover and biochemical markers in malignancy
// Cancer. — 1997. — V. 80(Suppl. 8). — P. 1538 1545.
Kanis J.A., McCloskey E.V., Powles T., Paterson A.H., Ashley S., Spector T.
A high
incidence of vertebral fracture in women with breast cancer // Br. J. Cancer. — 1999. —
V. 79(7 8). — P. 1179 1181.
Kao Y.C., Cam L.L., Laughton
è ñîàâò. The potent and selective inhibition of estro
gen production by non steroidal aromatase inhibitor YM511 // J. Ster. Bioch. Mol. Biol.
— 1995. — V. 54. — P. 265 271.
Karstens J.H., Schnabel B., Amman J.
Management of metastatic bone pain: prelim
inary results with single fraction (4Gy) radiotherapy // Oncologie. — 1989. — P. 41 42.
Kasalicky J., Krajska V.
The effect of repeated strontium 89 chloride therapy on
bone pain palliation in patients with skeletal cancer metastases // Eur. J. Nucl. Med.. —
1998. — V. 25(10). — P. 1362 1367.
Kaufmann E.
Pathology // In: Lechrbuch der Pathologishen Anatomie. —
Philadelphia: W.B. Sannders Co. — 1929.
Kaufmann M., Jonat W., Kleeberg U.
è ñîàâò. Goserelin, a depot gonadotropin
releasing hormone agonist in the treatment of premenopausal patients with metastatic
breast cancer // J. Clin. Oncol. — 1989. — V. 7. — P. 1113 1119.
Kawashima M., Maehara Y., Tateno K.
The effectiveness of radiation therapy in
bone metastasis from breast cancer // Rinsho Hoshasen. — 1989. — V. 34(4). — P. 501
505.
Kaye S.B., Woods R.L., Fox R.M., Coates A.S., Tattersall M.H.N.
Use of aminog
lutethimide as second line endocrin therapy in metastatic breast cancer // Cancer Res. —
1982. — V. 42. — P. 3445 3447.
Kellar J.
Oral morphine solution: effect of pain, confusion, drowsiness, and nausea
for terminally ill patient // Hosp. J. — 1988. — V.4(N1). — P. 55 64.
Kemp B.E., Moseley J.M., Rodda C.P.
è ñîàâò. Parathyroid hormone like protein of
malignancy: active synthetic fragments // Science. — 1987. — V. 237. — P. 1568 1570.
Kennealey G.T.
Combination chemotherapy for advanced breast cancer. Two
regimes containing adriamycin // Cancer. — 1978. — V. 42. — P. 27 33.
Kennedy B.J.
Diethylstillbestrol versus testosterone propionate therapy in advanced
breast cancer/ / Surg. Gynec. Obstet. — 1965. — V. 120. — P. 1246 1250.
233
Êîñòíûå ìåòàñòàçû ðàêà ìîëî÷íîé æåëåçû
